MTOR and breast carcinoma: This mechanism potentially has a significant impact on glucose uptake reduction, oxidative phosphorylation inhibition in breast cancer cells, ATP production decrease, intracellular ATP concentration reduction, AMPK phosphorylation enhancement at the Thr172 locus, decrease in p70S6K phosphorylation, and mammalian rapamycin-targeted mTOR inhibition.